Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2022-09-08 00:00:00 ET · period of report 2022-09-06 · accession 0001765581-22-000111 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-09-08 | 2022-09-06 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | S - Sale+OE | $153.18 | -7,703 | 353.3K | -2% | -$1.18M |
| D | 2022-09-08 | 2022-09-06 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $59.13 | +9,700 | 363.0K | +3% | +$573.6K |
| D | 2022-09-08 | 2022-09-06 | JAZZ | COZADD BRUCE C | COB, CEO, Dir | M - OptEx | $0.00 | -9,700 | 62.9K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-09-06 | S | D | 1,170 | $153.13 | 357,324 | D | — | — | (F4) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $152.87 to $153.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 2 | Common | Ordinary Shares | 2022-09-06 | S | D | 474 | $154.31 | 356,850 | D | — | — | (F5) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $153.93 to $154.66. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 3 | Common | Ordinary Shares | 2022-09-06 | S | D | 542 | $155.22 | 356,308 | D | — | — | (F6) Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $155.095 to $155.74. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 4 | Common | Ordinary Shares | 2022-09-06 | S | D | 4,517 | $152.41 | 358,494 | D | — | — | (F3) Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $151.87 to $152.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| 5 | Common | Ordinary Shares | 2022-09-06 | S | D | 1,000 | $155.10 | 353,311 | D | — | — | |
| 6 | Common | Ordinary Shares | 2022-09-06 | M | A | 9,700 | $59.13 | 363,011 | D | — | — | |
| 7 | Derivative | Non-Qualified Stock Option (right to buy) | 2022-09-06 | M | D | 9,700 | $0.00 | 62,905 | D | $59.13 · — to 2023-03-04 | 9,700 Ordinary Shares | (F7) This non-qualified stock option is part of an option granted on March 5, 2013. The ordinary shares subject to this option vested over 4 years from the grant date with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter and were fully vested as of March 5, 2017. |